Principal Financial Group
VERA icon

Principal Financial Group’s Vera Therapeutics VERA Stock Holding History

Principal Financial Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+4,888
New +$182K ﹤0.01% 2084
2024
Q3 		– Sell
-7,230
Closed -$262K – 2411
2024
Q2 		$262K Sell
7,230
-6,237
-46% -$247K ﹤0.01% 2086
2024
Q1 		$581K Buy
13,467
+147
+1% +$5.24K ﹤0.01% 1955
2023
Q4 		$205K Sell
13,320
-451
-3% -$5.73K ﹤0.01% 2165
2023
Q3 		$189K Buy
13,771
+533
+4% +$9.14K ﹤0.01% 2177
2023
Q2 		$212K Buy
+13,238
New +$120K ﹤0.01% 2167

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Principal Financial Group's VERA Position: Q2 2026 in Review

Principal Financial Group opened a new position in Vera Therapeutics (VERA) in Q2 2026: 4,888 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #2084 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in VERA as recently as Q2 2024.

Principal Financial Group first reported a position in VERA in Q2 2023 and has held it in 6 quarters since. The position peaked at $581K in Q1 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Principal Financial Group held 4,888 shares of Vera Therapeutics worth $210K as of Q2 2026.
  • Vera Therapeutics was a new Principal Financial Group position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2084 holding.
  • Principal Financial Group first reported a position in Vera Therapeutics in Q2 2023 and has held it in 6 quarters since.
  • Principal Financial Group's Vera Therapeutics position peaked at $581K in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.